266 related articles for article (PubMed ID: 25316911)
1. Actions of 1,25(OH)2-vitamin D3 on the cellular cycle depend on VDR and p38 MAPK in skeletal muscle cells.
Irazoqui AP; Boland RL; Buitrago CG
J Mol Endocrinol; 2014 Dec; 53(3):331-43. PubMed ID: 25316911
[TBL] [Abstract][Full Text] [Related]
2. 1α,25 dihydroxi-vitamin D₃ modulates CDK4 and CDK6 expression and localization.
Irazoqui AP; Heim NB; Boland RL; Buitrago CG
Biochem Biophys Res Commun; 2015 Mar; 459(1):137-42. PubMed ID: 25721671
[TBL] [Abstract][Full Text] [Related]
3. Role of VDR in 1α,25-dihydroxyvitamin D3-dependent non-genomic activation of MAPKs, Src and Akt in skeletal muscle cells.
Buitrago C; Pardo VG; Boland R
J Steroid Biochem Mol Biol; 2013 Jul; 136():125-30. PubMed ID: 23470620
[TBL] [Abstract][Full Text] [Related]
4. Effects of calcitriol on the cell cycle of rhabdomyosarcoma cells.
Irazoqui AP; Gonzalez A; Buitrago C
J Steroid Biochem Mol Biol; 2022 Sep; 222():106146. PubMed ID: 35710090
[TBL] [Abstract][Full Text] [Related]
5. 1α,25(OH)2D3-dependent modulation of Akt in proliferating and differentiating C2C12 skeletal muscle cells.
Buitrago CG; Arango NS; Boland RL
J Cell Biochem; 2012 Apr; 113(4):1170-81. PubMed ID: 22095470
[TBL] [Abstract][Full Text] [Related]
6. Induction of p21(Waf1/Cip1) by garcinol via downregulation of p38-MAPK signaling in p53-independent H1299 lung cancer.
Yu SY; Liao CH; Chien MH; Tsai TY; Lin JK; Weng MS
J Agric Food Chem; 2014 Mar; 62(9):2085-95. PubMed ID: 24533688
[TBL] [Abstract][Full Text] [Related]
7. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
Zhuang SH; Burnstein KL
Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
[TBL] [Abstract][Full Text] [Related]
8. Effects of 1,25(OH)2 D3 and 25(OH)D3 on C2C12 Myoblast Proliferation, Differentiation, and Myotube Hypertrophy.
van der Meijden K; Bravenboer N; Dirks NF; Heijboer AC; den Heijer M; de Wit GM; Offringa C; Lips P; Jaspers RT
J Cell Physiol; 2016 Nov; 231(11):2517-28. PubMed ID: 27018098
[TBL] [Abstract][Full Text] [Related]
9. 1alpha,25-Dihydroxyvitamin D(3) antiproliferative actions involve vitamin D receptor-mediated activation of MAPK pathways and AP-1/p21(waf1) upregulation in human osteosarcoma.
Wu W; Zhang X; Zanello LP
Cancer Lett; 2007 Aug; 254(1):75-86. PubMed ID: 17412493
[TBL] [Abstract][Full Text] [Related]
10. The vitamin D receptor mediates rapid changes in muscle protein tyrosine phosphorylation induced by 1,25(OH)(2)D(3).
Buitrago C; Vazquez G; De Boland AR; Boland R
Biochem Biophys Res Commun; 2001 Dec; 289(5):1150-6. PubMed ID: 11741312
[TBL] [Abstract][Full Text] [Related]
11. Caveolae and caveolin-1 are implicated in 1alpha,25(OH)2-vitamin D3-dependent modulation of Src, MAPK cascades and VDR localization in skeletal muscle cells.
Buitrago C; Boland R
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):169-75. PubMed ID: 20211253
[TBL] [Abstract][Full Text] [Related]
12. The effects of 1alpha,25-dihydroxyvitamin D3 on the expression of DNA replication genes.
Eelen G; Verlinden L; van Camp M; van Hummelen P; Marchal K; de Moor B; Mathieu C; Carmeliet G; Bouillon R; Verstuyf A
J Bone Miner Res; 2004 Jan; 19(1):133-46. PubMed ID: 14753745
[TBL] [Abstract][Full Text] [Related]
13. Resveratrol potentiates vitamin D and nuclear receptor signaling.
Dampf Stone A; Batie SF; Sabir MS; Jacobs ET; Lee JH; Whitfield GK; Haussler MR; Jurutka PW
J Cell Biochem; 2015 Jun; 116(6):1130-43. PubMed ID: 25536521
[TBL] [Abstract][Full Text] [Related]
14. 1,25(OH)2-vitamin D3 induces translocation of the vitamin D receptor (VDR) to the plasma membrane in skeletal muscle cells.
Capiati D; Benassati S; Boland RL
J Cell Biochem; 2002; 86(1):128-35. PubMed ID: 12112023
[TBL] [Abstract][Full Text] [Related]
15. Vitamin D receptor gene silencing effects on differentiation of myogenic cell lines.
Tanaka M; Kishimoto KN; Okuno H; Saito H; Itoi E
Muscle Nerve; 2014 May; 49(5):700-8. PubMed ID: 23873355
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factor binding protein-5 interacts with the vitamin D receptor and modulates the vitamin D response in osteoblasts.
Schedlich LJ; Muthukaruppan A; O'Han MK; Baxter RC
Mol Endocrinol; 2007 Oct; 21(10):2378-90. PubMed ID: 17595320
[TBL] [Abstract][Full Text] [Related]
17. Short-chain fatty acids and colon cancer cells: the vitamin D receptor--butyrate connection.
Gaschott T; Stein J
Recent Results Cancer Res; 2003; 164():247-57. PubMed ID: 12899527
[TBL] [Abstract][Full Text] [Related]
18. c-Jun NH2-teminal kinase 1 interacts with vitamin D receptor and affects vitamin D-mediated inhibition of cancer cell proliferation.
Bi X; Shi Q; Zhang H; Bao Y; Hu D; Pohl N; Fang W; Dong H; Xia X; Fan D; Yang W
J Steroid Biochem Mol Biol; 2016 Oct; 163():164-72. PubMed ID: 27174721
[TBL] [Abstract][Full Text] [Related]
19. MAP kinases p38 and JNK are activated by the steroid hormone 1alpha,25(OH)2-vitamin D3 in the C2C12 muscle cell line.
Buitrago CG; Ronda AC; de Boland AR; Boland R
J Cell Biochem; 2006 Mar; 97(4):698-708. PubMed ID: 16215981
[TBL] [Abstract][Full Text] [Related]
20. Stimulation of Sirt1-regulated FoxO protein function by the ligand-bound vitamin D receptor.
An BS; Tavera-Mendoza LE; Dimitrov V; Wang X; Calderon MR; Wang HJ; White JH
Mol Cell Biol; 2010 Oct; 30(20):4890-900. PubMed ID: 20733005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
